Atıf Formatları
Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. Piccart Et Al. , "Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer.," European journal of cancer (Oxford, England : 1990) , 2002

Piccart, M. Et Al. 2002. Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer.. European journal of cancer (Oxford, England : 1990) .

Piccart, M., Cardoso, F., & Atalay, G., (2002). Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer.. European journal of cancer (Oxford, England : 1990) .

Piccart, MJ, F Cardoso, And Gül BAŞARAN. "Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer.," European journal of cancer (Oxford, England : 1990) , 2002

Piccart, MJ Et Al. "Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer.." European journal of cancer (Oxford, England : 1990) , 2002

Piccart, M. Cardoso, F. And Atalay, G. (2002) . "Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer.." European journal of cancer (Oxford, England : 1990) .

@article{article, author={MJ Piccart Et Al. }, title={Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer.}, journal={European journal of cancer (Oxford, England : 1990)}, year=2002}